🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Miranda Orr OrrLab continues the Wake Forest Alzheimer's Disease Research Center Winter Full Investigators Meeting talking about the STOMP-AD senolytic therapy trial at Wake Forest University School of Medicine!

Trey Bateman Trey Bateman presents his work on COVID, stress and loneliness at the Wake Forest Alzheimer's Disease Research Center Winter Full Investigators Meeting at Wake Forest University School of Medicine! He may look alone up there, but he is not lonely.

I forgot to list on my biosketch all the effort I have to spend on updating and sending my biosketch

Susan M Landau presenting on the U.S. POINTER Imaging study HumanAmyloidImaging! This is an imaging ancillary to #USPOINTER, a multidomain lifestyle intervention trial led by researchers at Wake Forest Alzheimer's Disease Research Center Wake Forest Geriatric Medicine. Congratulations, Dr. Landau!

TugceD did a fantastic job discussing her work at Wake Forest Alzheimer's Disease Research Center on validating a telecognitive variation on the PACC!

Interested in using WF ADRC resources for your project? Click on WakeShare.org to find out what resources are available for your studies at the WF ADRC!

Are you attending AIC? (You should!) Are you a trainee? Don't miss the opportunity to take part in the mentoring session and to discuss with the expert of your choice over lunch! Fill this form by June 12 to register: docs.google.com/forms/d/e/1FAI…

Dr. Miranda Orr at Wake Forest Alzheimer's Disease Research Center led a national phase 1 study (tinyurl.com/bdeynh2a) to target senescent “zombie” cells, in work published in Nature Medicine (nature.com/articles/s4159…). Her pioneering research focuses on how changes that occur with aging influence AD risk! Congrats!

The Wake Forest Alzheimer's Disease Research Center will participate in the 2023 Walk to End Alzheimer’s (10am Sat. 11/4, Truist Stadium in Winston-Salem), as part of the Sticht Center for Healthy Aging and Alzheimer’s Prevention team. Please consider joining us, or donating at act.alz.org/goto/WakeADRC_…. Thank you!

Normal tau in Alzheimer's patients is not just explained by earlier disease stage -- it is linked to cardiovascular risk and older age, and alpha-synuclein copathology drives lower cognition. Thanks to Duygu Tosun Tessa Harrison, ADNI, and many others alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…

3 new pubs out of our group!

Congrats to Marc D Rudolph for leading this fascinating project!

Stop by Booth #921 at #AAIC24 to meet Samuel N. Lockhart, Ph.D., our newest team member and a renowned neuroscientist dedicated to advancing the understanding of neurodegenerative diseases.

Members of the ADACC Network, Drs. Hughes, Dage, Mielke, Craft, and Lockhart and other collaborators examined the use of neuroimaging-derived biomarkers of ADRD and the impact of health-related comorbidities. 🔖Read about their finding: alz-journals.onlinelibrary.wiley.com/doi/full/10.10…….

Attending #SNMMI 2024 Therapeutics in Bethesda, MD? Join us on Wed. 9/18 at the Streamlining Collaborations: Study Startups Workshop Session 3 at 4:15pm for Paolo Zanotti Fregonara’s session “Unique Challenges for Radiopharmaceutical Therapy (RPT) Trials - iCRO Perspective.”

Join us for a presentation on recent work from the B-NET study! Stephen Kritchevsky Invicro

Bateman et al, analyzing transcriptional data during the pandemic, found eudaimonic well-being inversely associated with CTRA gene expression (response to adverse social conditions) in participants with normal cognition & MCI. Trey Bateman Wake Forest Alzheimer's Disease Research Center alz-journals.onlinelibrary.wiley.com/doi/10.1002/da…

Meet Dr Samuel N. Lockhart, the moderator for the upcoming AD/PD™ Journal Club. Join him and his fellow expert speakers by securing your spot today! 📅 Date: 4th February 2025 ⏲️ Time: 16:00 CET Register Now: bit.ly/4asOG8p 👈 Dr. Samuel Lockhart is a Neuroscientist

The ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI) revolutionizes in vivo characterization of mixed pathologies. Learn about the creation of an unprecedented publicly available imaging–plasma–neuropath dataset in A&D: alz-journals.onlinelibrary.wiley.com/doi/10.1002/al… #AlzResearch